celecoxib has been researched along with pk 11195 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Bartels, AL; de Vries, EF; Dierckx, RA; Doorduin, J; Leenders, KL; Willemsen, AT | 1 |
1 trial(s) available for celecoxib and pk 11195
Article | Year |
---|---|
[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
Topics: Aged; Antiparkinson Agents; Brain; Brain Mapping; Case-Control Studies; Celecoxib; Cluster Analysis; Cyclooxygenase 2 Inhibitors; Female; Functional Laterality; Humans; Isoquinolines; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pilot Projects; Positron-Emission Tomography; Pyrazoles; Sulfonamides | 2010 |
1 other study(ies) available for celecoxib and pk 11195
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |